$REGN
Price history, market instrument context, member research, and related headlines in one place.
REGN key statistics
NasdaqGSUSD
52-week range
$566.1179%$859.34
Latest session $792.79–$809.49Regeneron Pharmaceuticals, Inc. (REGN) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $796.34, up $17.98 (2.31%) from the previous close of $778.36. It has traded between $792.79 and $809.49 in the latest session. Over the past year it has ranged from $566.11 to $859.34, leaving it in the upper quarter of its 52-week range (79%). Reported volume for the session was 798.8K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
FDA approves Regeneron’s Pasatru for rare bone disorder FOP — See source for full details.
Loading $REGN research…